As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

Syntara Limited (PMXSF) Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder Transcript

Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder July 5, 2026 11:30 PM ...
ascopubs.org

Dual targeting of VEGF and PD-1: A phase I/II trial of ivonescimab, a novel bispecific antibody, in recurrent glioblastoma.

Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
GlobalData on MSN

Kailera points to Phase III oral obesity drug data as it tees up Foundayo rivalry

Kailera’s in-licensed oral weight loss drug is currently in a global Phase II study for obesity.